Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-31T13:54:28.464Z Has data issue: false hasContentIssue false
  • English
  • Français

Living Organ Donation and Informed Consent in the United States: Strategies to Improve the Process

Published online by Cambridge University Press:  01 January 2021

Macey L. Henderson  and
Jed Adam Gross
Get access Rights & Permissions [Opens in a new window]

Abstract

About 6,000 individuals participate in the U.S. transplant system as a living organ donor each year. Organ donation (most commonly a kidney or part of liver) by living individuals is a unique procedure, where healthy patients undergo a major surgical operation without any direct functional benefit to themselves. In this article, the authors explore how the ideal of informed consent guides education and evaluation for living organ donation. The authors posit that informed consent for living organ donation is a process. Though the steps in this process are partially standardized through national health policy, they can be improved through institutional structures at the local, transplant center-level. Effective structures and practices aimed at supporting and promoting comprehensive informed consent provide more opportunities for candidates to ask questions about the risks and benefits of living donation and to opt out voluntarily Additionally, these practices could enable new ways of measuring knowledge and improving the consent process.

Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 45 , Issue 1: Under Attack: Reconceptualizing Informed Consent , Spring 2017 , pp. 66 - 76
Copyright
Copyright © American Society of Law, Medicine and Ethics 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Matas, A., Smith, J., and Skeans, M. et al., “OPTN/SRTR 2012 Annual Data Report: Kidney,” American Journal of Transplantation 14, no. S1 (2014): 11-44.CrossRefGoogle Scholar
Matas, supra note 1Google Scholar
Lidz, C. W., Appelbaum, P. S., and Meisel, A., “Two Models of Implementing Informed Consent,” Archives of Internal Medicine 148, no. 6 (1988):1385-1389.Google Scholar
Thiessen, C., Gordon, E., Reese, P., and Kulkarni, S., “Development of a Donor — Centered Approach to Risk Assessment: Rebalancing Nonmaleficence and Autonomy,“ American Journal of Transplantation 15, no. 9 (2015): 2314-2323.Google Scholar
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, “The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research,” (Washington, D.C.: U.S. Government Printing Office, 1978); F. Delmonico, “A Report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and Medical Guidelines,” Transplantation 79, Suppl. 6 (2005): S53.Google Scholar
Beauchamp, T. L. and Childress, J. F., Principles of Biomedical Ethics (New York: Oxford University Press, 2001): at 104.Google Scholar
Allen, M., Abt, P., and Reese, P., “What are the Harms of Refusing to Allow Living Kidney Donation? An Expanded View of Risks and Benefits,” American Journal of Transplantation 14, no.3 (2014): 531-537.CrossRefGoogle Scholar
Organ Procurement and Transplantation Network, Policy 14.4 “Medical Evaluation Requirements for Living Donors,” January 21, 2016 (2016): 181-187.Google Scholar
Allen, M. B. and Reese, P. P., “Transforming Living Kidney Donation with a Comprehensive Strategy,” PLoS Med, 13, no. 2 (2016): e1001948.Google Scholar
Gordon, E., Beauvais, N., Theodoropoulos, N., et al., “The Challenge of Informed Consent for Increased Risk Living Donation and Transplantation,” American Journal of Transplantation 11, no. 12 (2011): 2569-2574.CrossRefGoogle Scholar
Organ Procurement and Transplantation Network, Policy 14.4 “Medical Evaluation Requirements for Living Donors” (2016): 181-187.Google Scholar
Canterbury v. Spence 464 F.2d 772 (D.C. Cir. 1972).Google Scholar
Abecassis, M., Adams, M., and Adams, P. et al., “Consensus Statement on the Live Organ Donor,” JAMA, no. 22 284 (2000): 2919-2926. G. M. Danovitch, J. Chapman, A. M. Capron, et al., “Organ Trafficking and Transplant Tourism: The Role of Global Professional Ethical Standards — The 2008 Declaration of Istanbul,” Transplantation 95, no. 11 (2013):1306-1312.Google Scholar
Leichtman, A., Abecassis, M., Barr, M., et al., “Living Kidney Donor Follow-up: State-of-the-Art and Future Directions, Conference Summary and Recommendations,” American Journal of Transplantation 11, no. 12 (2011): 2561-2568.Google Scholar
Medicare and Medicaid Services Hospital Conditions of Participation: Requirements for Approval and Re-approval of Transplant Centers to Perform Organ Transplants: Final Rule. Federal Register 72, no. 61, (2007): 15197.Google Scholar
Medicare Program; Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers to Perform Organ Transplants; Final Rule. Federal Register. 2007;72 (61)).Google Scholar
Rudow, D. L., “The Living Donor Advocate: A Team Approach to Educate, Evaluate, and Manage Donors Across the Continuum,” Progress in Transplantation 19, no. 1 (2009): 64-70.CrossRefGoogle Scholar
Steel, J., Dunlavy, A., Friday, M., et al., “A National Survey of Independent Living Donor Advocates: The Need for Practice Guidelines,“ American Journal of Transplantation 12, no. 8 (2012): 2141-2149; J. L. Steel, A. Dunlavy, M. Friday, et al., “The Development of Practice Guidelines for Independent Living Donor Advocates,” Clinical Transplantation 27, no. 2 (2013): 178-184.CrossRefGoogle Scholar
Gordon, E., “Informed Consent for Living Donation: “A Review of Key Empirical Studies, Ethical Challenges and Future Research,” American Journal of Transplantation 12, no. 9 (2012): 2273-2280.CrossRefGoogle Scholar
Thiessen, C., Kim, Y., Formica, R., Bia, M., and Kulkarni, S., “Written Informed Consent for Living Kidney Donors: Practices and Compliance with CMS and OPTN Requirements,“ American Journal of Transplantation 13, no. 10 (2013): 2713-2721; J. Rodrigue, M. Pavlakis, G. Danovitch, et al., “Evaluating Living Kidney Donors: Relationship Types, Psychosocial Criteria, and Consent Processes at US Transplant Programs, “ American Journal of Transplantation 7, no. 10: (2007): 2326-2332.CrossRefGoogle Scholar
Organ Procurement and Transplantation Network, Policy 14.3, “Informed Consent Requirements” (2016): 177-181.Google Scholar
European Union Workgoup on Living Donation, Toolbox Living Kidney Donation: Action Plan on Organ Donation and Transplantation, 2009-2015,available at <http://ec.europa.eu/health//sites/health/files/blood_tissues_organs/docs/eutoolbox_living_kidney_donation_en.pdf>..>Google Scholar
Organ Procurement and Transplantation Network, Policy 14.3, “Informed Consent Requirements” (2016): 177-181.Google Scholar
Fink, A. S., Prochazka, A. V., and Henderson, W. G. et al., “Enhancement of Surgical Informed Consent by Addition of Repeat Back: A Multicenter, Randomized Controlled Clinical Trial,“ Annals of Surgery 252, no. 1(2010): 27-36.Google Scholar
Hays, R. E., “Informed Consent of Living Kidney Donors: Pitfalls and Best Practice,” Current Transplantation Reports 2, no. 1 (2015): 29-34.Google Scholar
Gordon, E., Mullee, J., Beauvais, N., et al., “Education and Informed Consent About Increased Risk Donor Kidneys: A National Survey of Non-physician Transplant Providers,” Transplant Infectious Disease 16, no. 2 (2014): 251-260.Google Scholar
Gordon, E. J., Reddy, E., Gil, S., et al., “Culturally Competent Transplant Program Improves Hispanics' Knowledge and Attitudes About Live Kidney Donation and Transplant,“ Progress in Transplantation 24, no. 1 (2014): 56-68.Google Scholar
Lentine, K. L., Schnitzler, M. A., Xiao, H., et al., “Racial Variation in Medical Outcomes among Living Kidney Donors,” NEJM 363, no. 8 (2010): 724-732.Google Scholar
Segev, D. L., Muzaale, A. D., Caffo, B. S., et al., “Perioperative Mortality and Long-term Survival Following Live Kidney Donation,” JAMA 303, no. 10 (2010): 959-966. A. D. Muzaale, A. B. Massie, M.-C. Wang, et al., “Risk of End-Stage Renal Disease Following Live Kidney Donation, “ JAMA 311, no. 6 (2014):579-586.Google Scholar
Grams, M. E., Sang, Y., Levey, A. S., et al., “Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate,” NEJM 374, no. 5 (2016) 411-421.Google Scholar
Parsa, A., Kao, W. L., Xie, D., et al., “APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease,“ NEJM 369, no. 23 (2013): 2183-2196.CrossRefGoogle Scholar
Phelan, P. J., Conlon, P. J., and Sparks, M. A., “Genetic Determinants of Renal Transplant Outcome: Where Do We Stand?” Journal of Nephrology 27, no. 3 (2014): 247:256.CrossRefGoogle Scholar
Ross, L. F. and Thistlethwaite, J. R., “Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation ApoL1 as a Case Study,” Progress in Transplantation, 3, no. 26 (2016): 203-6.CrossRefGoogle Scholar
Gordon, E., “Informed Consent for Living Donation: “A Review of Key Empirical Studies, Ethical Challenges and Future Research,” American Journal of Transplantation 12, no. 9 (2012): 2273-2280.CrossRefGoogle Scholar
Kortram, K., Lafranca, J. A., IJzermans, J. N., and Dor, F. J., “The Need for a Standardized Informed Consent Procedure in Live Donor Nephrectomy: A Systematic Review,” Transplantation 98, no. 11 (2014): 1134-1143.CrossRefGoogle Scholar
Faden, R. R. and Beauchamp, T. L., A History and Theory of Informed Consent (New York: Oxford University Press, 1986).Google Scholar
Organ Procurement and Transplantation Network, Policy 14.1 “Psychosocial Evaluation Requirements for Living Donors,” January 21, 2016 (2016): 175.Google Scholar
National Organ Transplant Act, (1984), 42 USC § 274e (2015).Google Scholar
OPTN, Policy 14.2 “Independent Living Donor Advocate (ILDA) Requirements,” January 21, 2106 (2016): 176.Google Scholar
Hays, R., LaPointe Rudow, D., Dew, M., Taler, S., Spicer, H., and Mandelbrot, D., “The Independent Living Donor Advocate: A Guidance Document From the American Society of Transplantation's Living Donor Community of Practice (AST LDCOP),” American Journal of Transplantation 15, no. 2 (2015): 518-525.Google Scholar
Chessa, F., “Informed Consent for Living Organ Donation,” Living Donor Advocacy (New York: Springer, 2014): at 261-274. I. Sajjad, L. S. Baines, M. Salifu, and R. M. Jindal, “The Dynamics of Recipient-Donor Relationships in Living Kidney Transplantation,” American Journal of Kidney Diseases 50, no. 5 (2007): 834-854; R. Hays and A. J. Matas, “Ethical Review of the Responsibilities of the Patient Advocate in Living Donor Liver Transplant,” Clinical Liver Disease 7, no. 3 (2016): 57-59.CrossRefGoogle Scholar
Chessa, supra note 39Google Scholar
Engelhardt, H. T., The Foundations of Bioethics (New York: Oxford University Press, 1996).Google Scholar
Lo, C.-M., “Evaluating the Living Donor: Expansion by Innovation,” Hepatology International 10 no. 2 (2016): 242-244.CrossRefGoogle Scholar
Parekh, A. M., Gordon, E. J., Garg, A. X., et al., “Living Kidney Donor Informed Consent Practices Vary Between US and Non-US Centers,” Nephrology Dialysis Transplantation 23, no. 10 (2008): 3316-3324.Google Scholar